Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2B | P41595 | 12/20 | 0.57 |
| ▸ | HTR2C | P28335 | 4/20 | 0.49 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.47 |
| ▸ | IGF1R | P08069 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | HTR3A | P46098 | 1/20 | 0.46 |
| ▸ | DAO | P14920 | 1/20 | 0.43 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9199296 | 0.98 | HTR2B (0.56) | HTR2BHTR2CPGAM1IGF1RALOX15 | |
| SCHEMBL6177760 | 0.95 | HTR2B (0.52) | HTR2BHTR2CPGAM1IGF1RALOX15 | |
| SCHEMBL6173771 | 0.92 | CNR1 (0.50) | HTR2BHTR2CMAPT | |
| SCHEMBL6174221 | 0.92 | HTR2B (0.49) | HTR2BHTR2CPGAM1IGF1RALOX15 | |
| SCHEMBL6176274 | 0.91 | IDH1 (0.49) | HTR2BHTR2CPGAM1IGF1RALOX15 | |
| SCHEMBL9196012 | 0.88 | HTR2B (0.46) | HTR2BHTR2CPGAM1IGF1RALOX15 | |
| SCHEMBL9195193 | 0.87 | HTR2B (0.45) | HTR2BHTR2CPGAM1IGF1RALOX15 | |
| SCHEMBL6174060 | 0.86 | HTR2B (0.44) | HTR2BHTR2CPGAM1IGF1RALOX15 | |
| SCHEMBL7449079 | 0.86 | HTR2B (0.44) | HTR2BHTR2CPGAM1IGF1RALOX15 | |
| SCHEMBL9199124 | 0.85 | IGF1R (0.46) | HTR2BHTR2CPGAM1IGF1RALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1203770-B1 | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases | UPJOHN CO (US) | 2005-03-09 | — | — | EP | disclosed |
| EP-0668860-B1 | PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | UPJOHN CO (US) | 2002-09-11 | — | — | EP | disclosed |
| EP-1203770-A1 | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases | PHARMACIA & UPJOHN COMPANY (US) | 2002-05-08 | — | — | EP | disclosed |
| EP-0668860-A1 | PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | PHARMACIA & UPJOHN COMPANY (US) | 1995-08-30 | — | — | EP | disclosed |
| WO-1994011361-A1 | PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | THE UPJOHN COMPANY (US) | 1994-05-26 | — | — | WO | disclosed |